Buy BPC 157 by Axiolabs at Best Anabolic Steroids. The vial is a lyophilised powder that is mixed with bacteriostatic water before use, and it holds one of the most discussed repair peptides in the research market: a synthetic chain of fifteen amino acids modelled on a fragment of a protein found in gastric juice.
It is worth being plain about the evidence before anything else. A systematic review located thirty-six studies on this peptide, thirty-five of them preclinical and only one in humans, so what follows describes laboratory and vendor reference data rather than a treatment plan. Nothing here is approved by any regulator for human use, and in sport the substance sits in the S0 class of non-approved agents.
Product Overview
The sequence is short and stable, which is why it survives conditions that destroy larger peptides: reports describe it remaining intact in human gastric juice for more than twenty-four hours and stable in urine for four days. Its recorded actions in animal models cluster around tissue repair - faster wound closure, reduced inflammatory signalling, support for new blood vessel formation and, in some work, a rise in growth hormone receptor expression.
What stands out is how fast the compound disappears from circulation. Measured elimination is between about eight and thirty minutes in rats after intravenous or intramuscular dosing, and no human figure is published at all. That extremely short life is the reason researchers and users speak about local rather than systemic effect, and it is also why the material is handled as a laboratory item with careful cold-chain practice instead of an off-the-shelf medicine.
Dosage Protocol
There is no approved dose, so the ladder below is a restatement of vendor and reference figures for research use. Amounts are tiny and are measured in micrograms, which is why reconstitution arithmetic matters more here than in any steroid card.
| Entry point | 250 mcg per day subcutaneously for one to two weeks, starting at the low end |
| Middle range | 250-500 mcg per day for two to four weeks, often split across two injections because clearance is so quick |
| Upper range | 500 mcg per day and above, used in blocks; beyond that there are no human data and the area is simply research |
| Women | No separate female protocol appears in the sources; none is confirmed |
| Route | Subcutaneous, with oral routes appearing in the research literature |
Reconstitution arithmetic
A 5 mg vial drawn up with 2 ml of bacteriostatic water gives 2.5 mg per ml, so 0.1 ml is 250 mcg, which reads as 10 units on a U-100 insulin syringe. A 10 mg vial with the same 2 ml gives 5 mg per ml, and the same 0.1 ml then carries 500 mcg. Keeping the vials, the water volume and the syringe units written down in one place removes the commonest mistake in this category.
Suggested Protocols
The peptide is used in short repair blocks, and the practical decisions are the amount, the site and how the mixed vial is kept. Rotating injection sites and working with clean technique matter more than small differences in dose, because the local reaction is the most frequently reported event.
Because it is a non-hormonal peptide, it sits outside the usual cycle logic: there is no base to add, no aromatase inhibitor to plan and no recovery drug to take afterwards. Users who pair it with other material in the same catalogue generally do so for separate reasons - a growth hormone product such as AxoTropin for a different goal entirely, or an anti-estrogen like Arimiplex as part of a steroid cycle that happens to overlap.
For the same reason, most readers arrive here in the middle of a heavier plan. The Axiolabs shelf covers that side of the kitchen as well: Testaplex E 250 as a base, Exeplex when estradiol needs managing, and the recovery pair Tamoxiplex 20 and Clomiplex 50 for the end of a cycle. None of them interacts with the peptide; they simply belong to the plan the peptide was added to.
What to Expect
- The time course is the weakest part of the evidence. Animal models show accelerated healing, but no human timeline is established, so any window quoted for people comes from user reports rather than from trials.
- Effects are described as local. With circulating levels gone within half an hour, the working assumption in the literature is a local action at the site of administration rather than a systemic one.
- Inflammation markers fall in laboratory work. Reductions in pro-inflammatory signalling are the most consistent finding across the preclinical material.
- Nothing is expected from a single injection. Blocks in the references run from one to four weeks, and short courses are the cautious choice given the data gap.
- Human safety data are thin. Reported events are mostly local, but the absence of trials is the real limitation, not a clean safety record.
- Competitive status is settled. The substance is prohibited in sport under the S0 category covering agents with no approval for human use.
Side Effects and Management
After the Course and Follow-Up
Post-cycle therapy does not belong on this card. The peptide works on local tissue signalling rather than through the hypothalamic-pituitary-gonadal axis, so it does not suppress natural testosterone production and there is no rebound to manage with a SERM. The follow-up that matters here is practical rather than hormonal.
Bacteriostatic water and the wider range are listed under the Axiolabs range on Best Anabolic Steroids, alongside support items such as Tamoxiplex 20 for anyone who is running a steroid cycle at the same time.
